Glaukos (GKOS)
(Delayed Data from NYSE)
$126.28 USD
+0.01 (0.01%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $126.23 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$126.28 USD
+0.01 (0.01%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $126.23 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Zacks News
Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: Glaukos, Daqo New Energy, Calavo Growers and Sucampo Pharmaceuticals
Medidata Solutions Clinical Cloud Gets Picked by Celgene
by Zacks Equity Research
Medidata Solutions Inc. (MDSO) recently announced that Celgene Corporation adopted Medidata Clinical Cloud.
Pacific Biosciences (PACB) to Sell 10 PacBio Sequel Systems
by Zacks Equity Research
Pacific Biosciences of California, Inc. (PACB), announced that it will sell 10 PacBio Sequel Systems to Novogene Bioinformatics Technology Company, Ltd.
5 Stocks with Recent Price Strength to Boost Your Returns
by Zacks Equity Research
One should primarily target stocks that have recently been on a bullish run. Actually, stocks seeing price strength recently have a high chance of carrying the momentum forward.
Akers Biosciences (AKER) Closes Offering of 1.7M Shares
by Zacks Equity Research
Akers Biosciences, Inc. (AKER) recently announced the closing of a public offering of 1.7 million common shares.
4 Profitable Stocks with Amazingly High Returns
by Zacks Equity Research
Net income ratio gives us the exact profitability level of a company and reflects the percentage of net income to total sales revenue.
Intuitive Surgical (ISRG) Expects Strong Revenues in Q4
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) announced that it expects fourth-quarter 2016 revenues of approximately $757 million.
Fluidigm: Q4 Preliminary Results Fail to Cheer Investors
by Zacks Equity Research
The market is not really happy with South San Francisco, CA-based Fluidigm Corporation's (FLDM) preliminary results for the fourth quarter and full-year 2016.
Ecolab (ECL) Acquires Abednego Environmental, Shares Gain
by Zacks Equity Research
In a bid to strengthen its water solution line of offerings, St. Paul, MN-based Ecolab Inc. (ECL) announced the acquisition of Abednego Environmental Services.
Can the Rally in Glaukos (GKOS) Shares Continue?
by Zacks Equity Research
Glaukos Corporation (GKOS) has been on the move lately as the stock has risen by 12.1% in the past four weeks, and it is currently trading well above its 20-Day SMA.
DexCom Looking Forward to Strong Revenues in Q4 and 2016
by Zacks Equity Research
DexCom, Inc. (DXCM), a renowned medical device company, reported that it expects preliminary, unaudited revenue of approximately $168 million for the fourth quarter ended Dec 31, 2016.
Integra LifeSciences at 52-Week High on Deals, View Update
by Zacks Equity Research
Shares of Integra LifeSciences Holdings Corporation (IART), a global leader in medical technology, scaled a new 52-week high of $45.50 on Jan 10, closing a tad lower at $44.90.
Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS
by Zacks Equity Research
Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.
Glaukos (GKOS) Catches Eye: Stock Adds 5.6% in Session
by Zacks Equity Research
Glaukos Corporation (GKOS) moved big last session, as its shares jumped almost 6% on the day.
4 Med Instrument Stocks for Q3 Earnings amid Election Chaos
by Zacks Equity Research
The medical device sector is positioned for impressive growth in the near term.
5 Great Growth Stocks To Buy Now
by Brian Bolan
Revenue growth is the single biggest factor in selecting an aggressive growth stock.